News

Under the terms of the distribution agreement, Alphamed will sell Arabio’s human vaccines and drugs in the UAE market. Arabio general manager Majed Bahatheq said that Arabio is

The assay is a molecular diagnostic assay that differentiates between patients at high, intermediate or low risk of early death after surgery to remove a non-squamous, non-small cell

Orteronel, discovered by Takeda, is an oral, non-steroidal androgen synthesis inhibitor that has been shown in pre-clinical studies to selectively inhibit the 17, 20 lyase enzymes which help

Bydureon is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes in multiple

The primary endpoint of the Phase 2 study is overall survival. A preliminary analysis of data from the study showed a difference in survival favoring the placebo plus

Bosutinib is an oral, once-daily, investigational dual Src and Abl kinase inhibitor with minimal inhibitory activity against c-kit and PDGFR. By dual inhibition of the Src and Abl

Under the term sheet for the co-promotion and sale agreement, Apricus will receive rights to co-promote Granisol and AQUORAL in the US, with exclusive promotion rights in certain

As per the extension, Novartis will fund research at GenVec through January 2013 to support its hearing loss and balance disorders program. GenVec has entered into a worldwide

INLYTA is an oral therapy designed to selectively inhibit vascular endothelial growth factor receptors 1, 2 and 3, which can influence tumor growth, vascular angiogenesis and progression of